Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.

Several factors are changing the landscape of cervical cancer control, including a better understanding of the natural history of human papillomavirus (HPV), reliable assays for detecting high-risk HPV infections, and a soon to be available HPV-16/18 vaccine. There are important differences in the relevant policy questions for different settings. By synthesizing and integrating the best available data, the use of modeling in a decision analytic framework can identify those factors most likely to influence outcomes, can guide the design of future clinical studies and operational research, can provide insight into the cost-effectiveness of different strategies, and can assist in early decision-making when considered with criteria such as equity, public preferences, and political and cultural constraints.

[1]  R. Anderson,et al.  Mathematical Models of the Transmission and Control of Sexually Transmitted Diseases , 2000, Sexually transmitted diseases.

[2]  B. Johns,et al.  Costs of scaling up health interventions: a systematic review. , 2005, Health policy and planning.

[3]  J. Fox-Rushby,et al.  Cost-Effectiveness Analysis for Priority Setting , 2006 .

[4]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  M J Buxton,et al.  Modelling in economic evaluation: an unavoidable fact of life. , 1997, Health economics.

[6]  Helen Trottier,et al.  Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. , 2006, American journal of epidemiology.

[7]  G. Garnett,et al.  Public health paradoxes and the epidemiological impact of an HPV vaccine. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  Paul C Langley.  Modeling for health care and other policy decisions: uses, roles, and validity. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[9]  Sue J Goldie,et al.  Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.

[10]  Milton C Weinstein,et al.  Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.

[11]  Geoffrey P Garnett,et al.  Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. , 2005, The Journal of infectious diseases.

[12]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[13]  M C Weinstein,et al.  Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  J. Wardle,et al.  Social and psychological impact of HPV testing in cervical screening: a qualitative study , 2006, Sexually Transmitted Infections.

[15]  Qaiser Mukhtar.  Global behavioral risk factor surveillance , 2005, Journal of Epidemiology and Community Health.

[16]  S. Goldie.  Chapter 15: Public health policy and cost-effectiveness analysis. , 2003, Journal of the National Cancer Institute. Monographs.

[17]  Stephen S. Lim,et al.  Methods to assess the costs and health effects of interventions for improving health in developing countries , 2005, BMJ : British Medical Journal.

[18]  M. Weinstein,et al.  Clinical Decision Analysis , 1980 .

[19]  S. Goldie.  Public health policy and cost-effectiveness analysis , 2003 .

[20]  M. Drummond,et al.  Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .

[21]  C. Murray,et al.  Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables. , 2002, International journal of technology assessment in health care.

[22]  B. Squires.  Methods for the Economic Evaluation of Health Care Programmes. , 1987 .